| 06th week of 2015 patent applcation highlights part 53 |
| Patent application number | Title | Published |
|---|
| 20150038693 | SIALIC ACID ANALOGS - The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies. | 2015-02-05 |
| 20150038694 | GLUCOSE DERIVATIVES BOUND TO ARSENIC FOR USE IN THE TREATMENT OF TUMOUR - A family of sugar-based molecules for therapeutic use, includes compounds with a structure having at least one sugar molecule with carrier function, bound to arsenic having active principle function, allowing the selective therapeutic treatment of tumoral pathologies and not, distinguished by a high cellular metabolism and, consequently, by a high glucose consumption. Based on the preferential glucose absorption according to the Warburg effect, the compounds are adapted to penetrate inside tumoral cells and not, distinguished by a high cellular metabolism, via the glucose molecule integrated in their structure, so as to determine the selective therapeutic treatment of the cells and, consequently, of the pathologies deriving therefrom, by the arsenic molecule chemically bound to above mentioned glucose molecule. Processes for the production of synthetic sugar-based compounds and extracted sugar-based compounds, produced from natural sources are also described. | 2015-02-05 |
| 20150038695 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND EFFICIENT METHODS OF PREPARING THEM - Embodiments of the invention provide regioselectively substituted carbohydrate and polysaccharide derivatives, such as cellulose esters, and methods for preparing them. Particular methods of the invention include deacylation of esters using tetrabutylammonium fluoride to obtain selective substitution at desired hydroxyl position(s) of the ester. Preferred is deacylation of an ester, which shows selectivity for removal of acyl groups from the ester of the secondary alcohols at C-2 and C-3, and which affords cellulose-6-O-esters with high regioselectivity by a simple one-step process employing no protective groups. Inventive regioselectively substituted cellulose esters can be prepared by such methods to obtain esters with the following anhydroglucose repeating units: | 2015-02-05 |
| 20150038696 | PROCESS FOR THE PREPARATION OF PURIFIED -(1,3)-D-GLUCANS - There is provided a process for the preparation of purified β-(1,3)-D-glucans, comprising the steps of providing an aqueous β-(1,3)-D-glucan initial solution having a pH of above 11.0, filtering the aqueous β-(1,3)-D-glucan initial solution to obtain a β-(1,3)-D-glucan containing filtrate, adjusting the pH of the β-(1,3)-D-glucan containing filtrate with an acid to a pH of below 5.0 to obtain an acidic β-(1,3)-D-glucan solution, and heating the acidic β-(1,3)-D-glucan solution to a temperature in the range of 60 to 160° C. | 2015-02-05 |
| 20150038697 | PROCESS FOR THE PREPARATION OF PURIFIED -(1,3)-D-GLUCANS - There is provided a process for the preparation of purified β-(1,3)-D-glucans, comprising the steps of providing an aqueous β-(1,3)-D-glucan initial solution having a pH of above 11.0, filtering the aqueous β-(1,3)-D-glucan initial solution to obtain a β-(1,3)-D-glucan containing filtrate, adjusting the pH of the β-(1,3)-D-glucan containing filtrate with an acid to a pH of below 5.0 to obtain an acidic β-(1,3)-D-glucan solution, and heating the acidic β-(1,3)-D-glucan solution to a temperature in the range of | 2015-02-05 |
| 20150038698 | PROCESS FOR THE PREPARATION OF PURIFIED BETA-(1,3)-D-GLUCANS - There is provided a process for the preparation of purified β-(1,3)-D-glucans, comprising the steps of providing an aqueous β-(1,3)-D-glucan initial solution having a pH of above 11.0, filtering the aqueous β-(1,3)-D-glucan initial solution to obtain a β-(1,3)-D-glucan containing filtrate, adjusting the pH of the β-(1,3)-D-glucan containing filtrate with an acid to a pH of below 5.0 to obtain an acidic β-(1,3)-D-glucan solution, and heating the acidic β-(1,3)-D-glucan solution to a temperature in the range of 60 to 160° C. | 2015-02-05 |
| 20150038699 | PROCESS FOR THE PREPARATION OF PURIFIED BETA-(1,3)-D-GLUCANS - There is provided a process for the preparation of purified β-(1,3)-D-glucans, comprising the steps of providing an aqueous β-(1,3)-D-glucan initial solution having a to pH of above 11.0, filtering the aqueous β-(1,3)-D-glucan initial solution to obtain a β-(1,3)-D-glucan containing filtrate, adjusting the pH of the β-(1,3)-D-glucan containing filtrate with an acid to a pH of below 5.0 to obtain an acidic β-(1,3)-D-glucan solution, and heating the acidic β-(1,3)-D-glucan solution to a temperature in the range of 60 to 160° C. | 2015-02-05 |
| 20150038700 | DORIPENEM INTERMEDIATE COMPOUND, PREPARATION PROCESS THEREFOR AND USE THEREOF, AND PREPARATION PROCESS FOR DORIPENEM - The present invention provides a doripenem intermediate compound shown by formula (XIV), wherein PNB is p-nitrobenzyl, and HX is an acid; and when HX is a monobasic acid, n=1; and when HX is a polybasic acid, n=2. The present invention also provides a process for preparing the doripenem intermediate compound (XIV). In addition, the present invention provides a process for preparing doripenem (I) from the doripenem intermediate compound (XIV) in a simple manner, with a high yield and low production costs. The new mono-protected doripenem intermediate compound provided in the present invention contains only one protecting group, reducing the difficulty and complexity in the subsequent de-protection step by catalytic hydrogenation, increasing the yield of the catalytic hydrogenation reaction, and thus reducing the production cost of the final product. The process is easy to operate and suitable for industrialized production. | 2015-02-05 |
| 20150038701 | PROCESSES FOR THE PREPARATION OF 8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE AND INTERMEDIATES RELATED THERETO - The present invention provides processes, methods and intermediates for the preparation of 8-chloro-1-methyl-2, 3,4,5-tetrahydro-1H-3-benzazepine, salts, hydrates and crystal forms thereof which are useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity. | 2015-02-05 |
| 20150038702 | Method of producing compounds having HIV integrase inhivitory activity - A process for preparing a compound represented by formula (Y1) or (Y2) | 2015-02-05 |
| 20150038703 | IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS - The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC). | 2015-02-05 |
| 20150038704 | METHOD FOR PREPARING RIVAROXABAN INTERMEDIATE - A method for preparing a Rivaroxaban intermediate I is presented, including the following step: in a non-protonic solvent, under the effect of lewis acid, performing cyclization reaction on 4-(4-phenyl isocyanate)morpholine-3-ketone (II) and (S)-epoxy compound (III), the reaction temperature ranging from 20° C. to 60° C., where R is amino replaced by amino protecting group. The preparation method of the present invention has a mild condition, a simple process, a low cost, and high efficiency; the product is easy to purify and the method is applicable to industrial production. | 2015-02-05 |
| 20150038705 | METHODS OF USE COMPRISING A BIOCIDAL POLYAMINE - Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, reduce biofilms, and/or inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms. | 2015-02-05 |
| 20150038706 | SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS - The invention relates to the synthesis of boronic ester and acid compounds. More particularly, the invention provides improved synthetic processes for the large-scale production of boronic ester and acid compounds, including the peptide boronic acid proteasome inhibitor bortezomib. | 2015-02-05 |
| 20150038707 | PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS - Methods for preventing pest infestations are disclosed. In some embodiments, the methods for preventing infestations involve use of pyrethroid insecticides or the stereoisomers or salts thereof. | 2015-02-05 |
| 20150038708 | SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN - In one aspect, the invention relates to substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs, derivatives thereof, and related compounds, which are useful as inhibitors of STAT protein activity; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders of uncontrolled cellular proliferation associated with a STAT protein activity dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 2015-02-05 |
| 20150038709 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038710 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038711 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038712 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038713 | SODIUM SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINE CARBOXAMIDE - A preparation replete with crystals of a sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide has superior solubility, and is useful as a preparation for injection. | 2015-02-05 |
| 20150038714 | Process for Synthesis of Chiral 3-Substituted Tetrahydroquinoline Derivatives - The present invention relates to novel and concise process for the construction of chiral 3-substituted tetrahyroquinoline derivatives based on proline catalyzed asymmetric α-functionalization of aldehyde, followed by in situ reductive cyclization of nitro group under catalytic hydrogenation condition with high optical purities. Further the invention relates to conversion of derived chiral 3-substituted tetrahydroquinoline derivatives into therapeutic agents namely (−)-sumanirole (96% ee) and 1-[(S)-3-(di-methylamino)-3,4-dihydro-6,7-dimethoxy-quinolin-1(2H)-yl]propanone[(S)-903] (92% ee). | 2015-02-05 |
| 20150038715 | PROCESS - The present invention provides a process for preparing an oxymorphone acid adduct, said process comprising hydrogenating an aqueous solution of 14-hydroxymorphinone and an acid to form a solution of the oxymorphone acid adduct, wherein the hydrogenation is carried out at one or more temperatures greater than 40° C. in the presence of a hydrogenation catalyst and hydrogen gas, wherein the level of 6α-oxymorphol produced is ≦3.00 area % as determined by HPLC. | 2015-02-05 |
| 20150038716 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038717 | METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND - A method for making the compound | 2015-02-05 |
| 20150038718 | LABELED IODINATED TROPANE FORMULATION - A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [ | 2015-02-05 |
| 20150038719 | Agent for Ameliorating Chronic Obstructive Pulmonary Disease - This invention provides a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect. The agent for ameliorating chronic obstructive pulmonary disease contains mepenzolate bromide as an active ingredient. More preferably the mode of administration of the agent for ameliorating chronic obstructive pulmonary disease is airway administration or inhalation administration, and furthermore the mode of administration thereof is oral administration or rectal administration. This invention is a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect of mepenzolate bromide. | 2015-02-05 |
| 20150038720 | Low-Temperature Synthesis of Methylphenidate Hydrochloride - The present invention describes a process for the preparation of methylphenidate hydrochloride. The process involves the esterification of ritalinic acid and methanol in the presence of an acid catalyst at a low temperature. The process may optionally involve the addition of an orthoester. | 2015-02-05 |
| 20150038721 | SOLID FORMS OF DABIGATRAN ETEXILATE MESYLATE AND PROCESSES FOR THEIR PREPARATION - It relates to solid forms of dabigatran etexilate mesylate, in particular dabigatran etexilate mesylate in crystalline Form A, and in amorphous form; to processes for their preparation, and to pharmaceutical compositions comprising them. It also relates to a crystalline form of dabigatran etexilate base (Form A), and to a process for its preparation. | 2015-02-05 |
| 20150038722 | ORGANIC COMPOUND, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE - An organic compound represented by General Formula (G100) is provided. A novel liquid crystal composition containing the organic compound is provided. | 2015-02-05 |
| 20150038723 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS - Akylidene complexes of ruthenium containing N-heterocyclic carbene ligands and their use as highly active, selective catalysts for olefin metathesis | 2015-02-05 |
| 20150038724 | IMIDAZOLIDINE-BASED METAL CARBENE METATHESIS CATALYSTS - The present invention relates to novel metathesis catalysts with an imidazolidine-based ligand and to methods for making and using the same. The inventive catalysts are of the formula | 2015-02-05 |
| 20150038725 | PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS - The invention provides processes for preparing intermediates useful for preparing compounds of the formula: | 2015-02-05 |
| 20150038726 | PROCESS FOR THE PREPARATION OF CARBAPENEM ANTIBIOTIC - The present invention provides an improved process for the preparation Ertapenem monosodium of formula (I) having purity greater than 98.5% and having pharmaceutically acceptable level of palladium and residual solvent. (I) | 2015-02-05 |
| 20150038727 | METHOD FOR PREPARING SILODOSIN - The present invention relates to a process for preparing silodosin with high optical purity up to 99.9% enantiomeric excess (e.e.) or above. The process makes use of a method step, in which the enantiomers contained in a racemic mixture of a compound represented by the general formula V: wherein * denotes the asymmetric center, R | 2015-02-05 |
| 20150038728 | NOVEL ARYLATED CAMPHENES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF - The present invention relates to arylated camphenes, processes for their preparation and uses thereof for the manufacture of medicaments for the treatment of diseases, disorders or conditions associated with, or benefiting from stimulation of CB2 receptors. | 2015-02-05 |
| 20150038729 | Method for processing rice-oil - According to the present invention there is provided a method of processing rice oil comprising the steps of removing one or more phosphorus compounds from the rice oil; heating the rice oil to a temperature of between 200° C.-260° C.; applying a pressure of between 0.1-1 kgf/cm | 2015-02-05 |
| 20150038730 | BLOWN AND STRIPPED PLANT-BASED OILS - A method for producing a high viscosity, low volatiles blown stripped plant-based oil is provided. The method may include the steps of: (i) obtaining a plant-based oil; (ii) heating the oil to at least 90° C.; (iii) passing air through the heated oil to produce a blown oil having a viscosity of at least 50 cSt at 40° C.; (iv) stripping the blown oil from step (iii) to reduce an acid value of the blown oil to from 5 mg KOH/g to about 9 mg KOH/g; (v) adding a polyol to the stripped oil from (iv); and (vi) stripping the oil from step (v) to reduce the acid value of the oil to less than 5.0 mg KOH/g or less. | 2015-02-05 |
| 20150038731 | PROCESS FOR PREPARING CARBOXYLIC ACIDS - The present invention relates to a process of making a compound of formula (XII) or (XIIA): wherein R | 2015-02-05 |
| 20150038732 | CYANOBIPHENYL DERIVATIVE, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE - A novel material for a liquid crystal composition that can be used for various liquid crystal devices is provided. A novel cyanobiphenyl derivative represented by General Formula (G1) is provided. In General Formula (G1), R | 2015-02-05 |
| 20150038733 | METHOD FOR SYNTHESIZING RAMALIN AND RAMALIN PRECURSOR BY USING GLUTAMIC ACID DERIVATIVE AND HYDROXY ANILINE OR HYDROXY ANILINE HAVING PROTECTED HYDROXY GROUP - Disclosed is a method of the synthesis of ramalin. It comprises reacting a glutamic acid derivative, which is prepared using alkylchloroformate, with a hydrazine salt compound, which is prepared from hydroxy aniline, whether protected or not. The synthesis method allows ramalin, excellent in antioxidant and anti-inflammatory activity, to be simply synthesized at stable yield even without use of a highly toxic solvent such as DMF. In addition, the method is cost competitive, and provides ramalin at high efficiency, thus enabling the mass production of ramalin. | 2015-02-05 |
| 20150038734 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE - A method for making an alkyl 3-hydroxybutyrate is provided. The method can include reacting an alkyl alcohol with diketene to form an alkyl acetoacetate and then hydrogenating the alkyl acetoacetate to form the alkyl 3-hydroxybutyrate. The method of the present invention may also include separating one or more impurities an alkyl acetoacetate stream and subjecting the purified acetoacetate mixture to hydrogenation to form the alkyl 3-hydroxybutyrate. Methods of the present invention can be carried out on a lab, pilot, or commercial scale. | 2015-02-05 |
| 20150038735 | PREPARATION OF ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS AND ESTERS THEREOF - An L-type zeolite, a modified L-type zeolite, or any combination thereof may be useful in catalytically preparing α,β-unsaturated carboxylic acids and/or esters thereof through reaction pathways that include dehydroxylation reactions and optionally esterification reactions. In some reaction pathways, dehydroxylation reactions and esterification reactions may be performed sequentially or concurrently. | 2015-02-05 |
| 20150038736 | VERTICAL CENTRIFUGAL THIN FILM EVAPORATOR AND MONOMER PURIFICATION METHOD - A vertical centrifugal thin film evaporator is equipped with: a cylindrical body in which an central axis of a circle is set in a vertical direction; a rotor that rotates an interior of the cylindrical body in a circumferential direction thereof; a wiper that slides on an inner circumferential surface of the cylindrical body; a fixing support that fixes the wiper and is mounted on the rotor; and a heater that heats a circumferential surface of the cylindrical body. A liquid-withdrawing structure that communicates between a space surrounded by the wiper and the fixing support and a space outside the wiper and the fixing support is formed on at least one of the wiper and the fixing support, thereby preventing a liquid to be processed from being retained between the wiper and the fixing support. | 2015-02-05 |
| 20150038737 | Process And System For Purification Of Aromatic Dicarboxylic Acid - In a process/system for the purification of aromatic dicarboxylic acid (ACA), crude ACA solids are slurried with water recycled from at least a filtration step in a feed preparation zone. Flash steam in vapour phase is supplied to the zone from at least one of a crystallisation step, a filtration step, and a drier step. The slurried ACA solids are preheated to form a solution that is then hydrogenated. The ACA is allowed to crystallise and then crystals of pure ACA are filtered out and water is recovered in a single stage filtration process. Recovered water is supplied to the feed preparation zone and the crystals are dried and recovered. The flash steam recovered from the crystallisation step, filtration step and/or drier step is recovered as a vapour phase stream having a pressure from about atmospheric to 5 barg and supplied to the feed preparation zone without phase change. | 2015-02-05 |
| 20150038738 | Optical Resolution Methods for Bicyclic Compounds Using Enzymes - An object of the present invention is to efficiently produce an optically active bicyclic compound. The optically active bicyclic compound is efficiently produced using an enzyme. | 2015-02-05 |
| 20150038739 | METHOD FOR MANUFACTURING REFINED METHIONINE - The object of the present invention is to provide a process for producing refined methionine in which the loss of methionine due to washing is reduced. The present invention relates to a process for producing refined methionine from crude methionine, comprising a step of washing crude methionine with the use of a wash water containing methionine. | 2015-02-05 |
| 20150038740 | ALANYL GLUTAMINE COMPOUND AND PREPARATION METHOD THEREOF - A process for preparing a pure alanylglutamine comprises the steps of: 1) reacting N-(α-chloro)-propionyl-glutamine and hydrazine compound to obtain an alanylglutamine crude product; 2) mixing anhydrous methanol and the alanylglutamine crude product to provide a filter cake; 3) dissolving the filter cake in water, heating, adding ethanol, and cooling to yield the pure alanylglutamine. | 2015-02-05 |
| 20150038741 | APPARATUS FOR PRODUCTION OF HIGH PURITY CARBON MONOXIDE - A device and a process for producing high purity CO by electrolysis of CO2 in a Solid Oxide Electrolysis Cell stack and a gas separation unit, also the gas separation unit may be a Solid Oxide Electrolysis Cell stack. | 2015-02-05 |
| 20150038742 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester - The present invention provides a method for producing N-substituted carbamic acid-O-aryl ester derived from a compound having an ureido group, the method comprising the step of carrying out esterification or esterification and transesterification from the compound having the ureido group and a hydroxy composition containing one type or a plurality of types of hydroxy compounds. | 2015-02-05 |
| 20150038743 | Efficient Continuous Process for Manufacturing of 4-Aminodiphenylamine From Aniline and Nitrobenzene - An efficient continuous manufacturing process for 4-aminodiphenylamine by coupling aniline with nitrobenzene in the presence of tetramethylammonium hydroxide (TMAH) as a base, using flow reactors wherein base decomposition is considerably reduced by optimizing base quantity, process conditions and process equipment. | 2015-02-05 |
| 20150038744 | Crystalline Solid Rasagiline Base - The subject invention provides crystalline R(+)-N-propargyl-1-aminoindan, pharmaceutical compositions and methods of manufacture thereof. | 2015-02-05 |
| 20150038745 | COOLED REACTOR FOR THE PRODUCTION OF DIMETHYL ETHER FROM METHANOL - A cooled reactor for the production of dimethyl ether by catalytic dehydration of methanol in the gas phase, the reactor having an adiabatic catalyst bed as starting zone, a moderator zone cooled by direct or indirect heat exchange, and optionally an adiabatic catalyst bed as conditioning zone. The conversion of methanol to dimethyl ether is increased and the formation of undesired by-products is decreased. | 2015-02-05 |
| 20150038746 | Process for the Preparation of Nitroalcohols - A process of preparing a nitroalcohol, e.g., 2-nitro-2-methyl-1-propane, from a nitropolyol, e.g., 2-nitro-2 -methyl-1,3-propanediol, the process comprising the step of contacting under hydrogenation conditions the nitropolyol with hydrogen, a hydrogenation catalyst and, optionally, a chelating agent. | 2015-02-05 |
| 20150038747 | Process for Producing Phenol - In a process for producing phenol, cyclohexylbenzene is oxidized to form a first reaction product comprising cyclohexylbenzene hydroperoxide and at least a portion of the cyclohexylbenzene hydroperoxide is then cleaved to form a second reaction product comprising phenol and cyclohexanone. At least one of the first and second reaction products comprises cyclohexenone, which is hydrogenated to produce further cyclohexanone. | 2015-02-05 |
| 20150038748 | HYDROPHILIC MEMBRANE INTEGRATED OLEFIN HYDRATION PROCESS - A membrane-integrated hydration reactor that is operable to produce an associated alcohol product from an olefin using water includes a solid acid olefin hydration catalyst in a production zone and a hydrophilic membrane operable to selectively permit pervaporation of water one-way and not permit pervaporation of the associated alcohol or permeation of the olefin at olefin hydration process conditions in a separations zone. The production zone is operable to form a production zone product mixture made of the associated alcohol and any unreacted water. The associated separations zone is operable to form and produce both the associated alcohol product and a pervaporated water product from the production zone product mixture. A method of olefin hydration for forming an associated alcohol product from an olefin using water uses the membrane-integrated hydration reactor at olefin hydration process conditions. | 2015-02-05 |
| 20150038749 | Process for Producing 2-Chloro-1,3,3,3-Tetrafluoropropene - Disclosed is a process for producing 2-chloro-1,3,3,3-tetrafluoropropene (1224), including a first step of separating 2,3-dichloro-1,1,1,3-tetrafluoropropane 234da) into erythro form and threo form, and a second step of bringing the separated erythro form or threo form in contact with a base to obtain 2-chloro-1,3,3,3-tetrafluoropropene (1224). The first step is a step of separating 234da by distillation to achieve a separation into a fraction containing mainly erythro form and a fraction containing mainly threo form. In the second step, 1224 cis form is obtained from the erythro form, and 1224 trans form is obtained from the threo form. By this process, it is possible to selectively and efficiently produce cis form or trans form of 2-chloro-1,3,3,3-tetrafluoropropene (1224). | 2015-02-05 |
| 20150038750 | ELECTROCHEMICAL HYDROXIDE SYSTEMS AND METHODS USING METAL OXIDATION - There are provided methods and systems for an electrochemical cell including an anode and a cathode where the anode is contacted with a metal ion that converts the metal ion from a lower oxidation state to a higher oxidation state. The metal ion in the higher oxidation state is reacted with an unsaturated hydrocarbon and/or a saturated hydrocarbon to form products. Separation and/or purification of the products as well as of the metal ions in the lower oxidation state and the higher oxidation state, is provided herein. | 2015-02-05 |
| 20150038751 | BIMETAL CATALYSTS - The present disclosure discloses bimetal catalysts. | 2015-02-05 |
| 20150038752 | SYSTEMS AND METHODS OF PRODUCING AROMATIC PRODUCTS - Systems and methods for producing aromatic products are provided. An aromatic stream is provided with aromatic compounds and olefins. The olefins are reacted with aromatic compounds to form colored bodies, and the aromatic stream is distilled to produce an overhead stream and reboiler stream. The colored bodies are in the reboiler stream, and the reboiler stream is passed through an absorbent to remove the colored bodies. | 2015-02-05 |
| 20150038753 | Olefin Oligomerization Process - The invention provides an olefin oligomerization process comprising the steps of: i) reducing the level of nitriles in an olefin feed by contacting the feed with a guard bed comprising gamma alumina having a surface area greater than 250 m | 2015-02-05 |
| 20150038754 | Phosphorus Modified Molecular Sieves, Their Use In Conversion of Organics to Olefins - A phosphorous modified zeolite (A) can be made by a process that includes selecting a zeolite, steaming the zeolite, leaching the zeolite, separating solids from liquid, and calcining. An olefin product can be made from an oxygen-containing, halogenide-containing or sulphur-containing organic feedstock by contacting the feedstock with the phosphorous modified zeolite (A) in an XTO reactor under conditions effective to convert at least a portion of the feedstock to olefin products. The XTO reactor effluent can include light olefins and a heavy hydrocarbon fraction. The light olefins can be separated from the heavy hydrocarbon fraction. The heavy hydrocarbon fraction can be contacted in an OCP reactor at conditions effective to convert at least a portion of the heavy hydrocarbon fraction to light olefins. | 2015-02-05 |
| 20150038755 | PROCESSES AND SYSTEMS FOR SEPARATING STREAMS TO PROVIDE A TRANSALKYLATION FEED STREAM IN AN AROMATICS COMPLEX - A process and system for the production of at least one xylene isomer is provided. The process includes passing a first stream to one side of a split shell fractionation column and a second stream to the other side of the column. The first stream has a higher ratio of methyl to C2+ alkyl-substituted C9 aromatic compounds than the second stream. A bottoms stream from the one side is separated and passed as feed to a transalkylation zone. | 2015-02-05 |
| 20150038756 | ITQ-49 MATERIAL, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAME - The present invention refers to a microporous crystalline material, to the method for the production thereof and to the use of same, the material having a composition: | 2015-02-05 |
| 20150038757 | METHOD FOR QUENCHING PARAFFIN DEHYDROGENATION REACTION IN COUNTER-CURRENT REACTOR - A process is presented for quenching a process stream in a paraffin dehydrogenation process. The process comprises cooling a propane dehydrogenation stream during the hot residence time after the process stream leaves the catalytic bed reactor section. The process includes cooling and compressing the product stream, taking a portion of the product stream and passing the portion of the product stream to the mix with the process stream as it leaves the catalytic bed reactor section. | 2015-02-05 |
| 20150038758 | PREPARATION METHOD OF PLATINUM/TIN/METAL/ALUMINA CATALYST FOR DIRECT DEHYDROGENATION OF n-BUTANE AND METHOD FOR PRODUCING C4 OLEFINS USING SAID CATALYST - The provided is a method for preparing a platinum-tin-metal-alumina catalyst by comprising: as an active ingredient, platinum which has a high activity in a direct dehydrogenation reaction of n-butane, tin which can increase the catalyst stability by preventing carbon deposition; additionally metal for reducing the level of catalyst inactivation over the reaction time; and an alumina carrier for supporting said components. Further, provided is a method for producing a high value product, C4 olefins from low cost n-butane by using the catalyst prepared by the method according to the present invention in a direct dehydrogenation reaction. | 2015-02-05 |
| 20150038759 | REMOVAL OF SULFUR COMPOUNDS IN AN ACID GAS STREAM GENERATED FROM SOLVENT-BASED GAS TREATING PROCESS - The invention involves a process for treating a natural gas stream comprising sending the natural gas stream first to an adsorbent unit for removal of mercury. Then the gas stream is sent to an absorbent unit containing a chemical solvent and a physical solvent for removal of carbon dioxide, hydrogen sulfide, carbonyl sulfide and organic sulfur compounds to produce a partially purified natural gas stream. This stream is dehydrated and becomes the product stream. The partially purified natural gas stream to a dehydration unit to remove water to produce a natural gas product stream. The impurities absorbed by the absorption unit are removed and a liquid stream is separated that contains the sulfur impurities. This liquid stream may be purified and stabilized before being shipped for further treatment. | 2015-02-05 |
| 20150038760 | METHOD FOR PROCESSING RADIOACTIVELY-CONTAMINATED WATER - The present invention provides an efficient and low cost method for processing radioactively-contaminated water. The method for processing radioactively-contaminated water comprising a freeze concentration step of generating ice having lowered concentration of radioactive substance from radioactive substance containing contaminated water and concentrating the radioactive substances in the residual contaminated water by the interface progressive freeze concentration process. Preferably, the method further comprises a nitrogen substitution step of reducing dissolved oxygen in the contaminated water and adding nitrogen gas to the contaminated water, as a previous step of the freeze concentration step. Preferably, the radioactive substance is radioactive cesium. | 2015-02-05 |
| 20150038761 | GRAPHENE-AU NANOPLATE STRUCTURE, METHOD FOR FABRICATING THE SAME, AND METHOD FOR ACCELERATING CARBON IONS USING THE GRAPHENE-AU NANOPLATE STRUCTURE - A graphene-Au nanoplate structure, a method for fabricating the same, and a method for accelerating carbon ions using the graphene-Au nanoplate structure. The graphene-Au nanoplate structure includes: a substrate; an Au nanoplate attached on the substrate; and a graphene wrapped around the Au nanoplate. | 2015-02-05 |
| 20150038762 | METHOD FOR PREPARING AN IRRADIATION PLAN FOR A MOVING TARGET VOLUME WITHOUT A MOVEMENT COMPENSATION - A method for preparing a radiation treatment plan for irradiating a target volume region moving in regions in an object with a moving particle beam includes determining, using a mapping function dependent on a movement state (k) of the moving target volume region, a dose input in at least one target point volume (Vj). The dose input is brought about by applying the particle beam to an irradiation point (Bi). | 2015-02-05 |
| 20150038763 | RADIOTHERAPY EQUIPMENT CONTROL DEVICE, RADIOTHERAPY EQUIPMENT CONTROL METHOD, AND PROGRAM EXECUTED BY COMPUTER FOR RADIOTHERAPY EQUIPMENT - A radiotherapy equipment control device acquires reference position information for a specific location at a reference time. Furthermore, representative point reference position information is generated from reference position information for a plurality of markers at the reference time, and relative position information up to the reference position information for the specific location is generated. Moreover, representative point position information at another time is generated from the position information for a plurality of markers in a subject at the other time, which differs from the reference time. In addition, position information for the specific location at the other time is generated from the representative point position information and the relative position information. In this case, representative point reference position information and representative position information are generated on the basis of the position information and reference position information for the plurality of markers, said information having been weighted by weighting factors. | 2015-02-05 |
| 20150038764 | CHARGED PARTICLE BEAM TRANSPORT SYSTEM AND PARTICLE BEAM THERAPY SYSTEM - A charged particle beam transport system is characterized in that in a fixed transport unit, a phase of a phase space distribution of a charged particle beam at an inlet of a rotating deflection unit that rotates around an gantry rotation axle of a rotating gantry coincides with a phase determined by a calculation based on an average value of a first phase advance and a second phase advance. The first phase advance is defined as a change in a phase, of the phase space distribution, that changes when the charged particle beam travels from the inlet of the rotating deflection unit to an isocenter in the case where a gantry angle is a gantry reference angle; the second phase advance is defined as a change in a phase at a time when the gantry angle is pivoted by 90° from the gantry reference angle. | 2015-02-05 |
| 20150038765 | USING DIFFERENT INDICATORS FOR DETERMINING POSITIONAL CHANGES OF A RADIOTHERAPY TARGET - The present invention relates to a method for determining data referred to as target change data which can be used for performing radiotherapy treatment, the target change data describing information on the change of position of a target included in a body of a patient, the method being performed by a computer and comprising the following steps:
| 2015-02-05 |
| 20150038766 | PARTICLE BEAM SCANNING IRRADIATION SYSTEM - A particle beam scanning irradiation method includes the steps of calculating a planned irradiating particle count of a particle beam for each of irradiation spots, on the basis of a relative amount of particle beam irradiation and a prescription particle-beam dose determined from a particle-beam therapy plan; simulating an irradiation process of the particle beam at each irradiation spot, on the basis of the planned irradiating particle count and a beam current waveform of the particle beam, and calculating a particle count of the particle beam irradiating the diseased portion during a scan shift of the particle beam; correcting the planned irradiating particle count for each irradiation spot by using the irradiating particle count during the scan shift; converting the corrected planned-irradiation particle count into a count value used in a dose monitor; and irradiating the irradiation spot with the particle beam, on the basis of the converted count value. | 2015-02-05 |
| 20150038767 | ENDORECTAL BALLOON WITH GAS LUMEN AND STOPPER - A prostate immobilizing balloon having a central seating area that on full inflation cups the prostate to hold it during treatment is combined with a gas lumen, a locking member and one or more fiducial markers. Methods of using same are also provided. | 2015-02-05 |
| 20150038768 | TRANSCRANIAL MAGNETIC STIMULATION SYSTEM - A transcranial magnetic stimulation system has a magnetic field generating means for generating a variable magnetic field to be used for providing magnetic stimulation to a specific part of the patient's head. The system also has a holder for holding a magnetic coil of the magnetic field generating means, cameras for recognizing respective reference markings or specific portions of ears of the patient (tragi), and laser beam oscillators. According to the system, the coil is set in a proper posture with respect to the specific part of the patient by aligning the optical axes of the cameras and the laser beam oscillators with respective tragi. | 2015-02-05 |
| 20150038769 | AXIAL FLOW PUMP WITH MULTI-GROOVED ROTOR - An axial-flow blood pump for pumping blood includes a substantially cylindrical outer enclosure. A tubular housing concentric with and located within the outer enclosure has at one end an inlet and at an opposite end an outlet. A motor stator is concentric with and located between the outer enclosure and the tubular housing. An impeller is concentric with and located within the tubular housing. The impeller is suspended in operation by a combination of passive magnetic forces between magnets within the impeller or magnetized regions of the impeller and the motor stator and hydrodynamic thrust forces generated as blood flows between the tubular housing and a plurality of hydrodynamic thrust bearing surfaces located on the impeller. A volute may be in fluid-tight connection with the outlet of the tubular housing for receiving blood in the axial direction and directing blood in a direction normal to the axial direction. The volute has a flow-improving member extending axially from the volute and into and coaxially with the tubular housing. | 2015-02-05 |
| 20150038770 | WIRE SCAFFOLD DEVICE FOR VENTRICULAR ASSIST DEVICE - A ventricular assist system includes a ventricular assist device (“VAD”) and an expandable stent. The VAD may include a pump and an inlet element defining an inlet opening communicating with the pump, the inlet element being adapted for positioning with the inlet opening disposed within a ventricle of a heart when the system is in an operative condition. The expandable stent may be adapted for positioning within the ventricle when the system is in the operative condition. The pump may be operated to draw blood from the ventricle and return the blood to the artery, and a wall of the ventricle may be held away from the inlet opening with the stent. The stent may be passed through a channel in the ventricular assist device while the stent is in a collapsed condition. | 2015-02-05 |
| 20150038771 | IMPLANTABLE SYSTEM WITH SECURE REMOTE CONTROL - A fluid flow system for a patient comprises a controller and an implantable pump assembly. The controller comprises a processing unit and a battery. The processing unit includes a signal generator and one or more pump operational parameters. The signal generator provides a drive signal. The battery provides power to the processing unit. The implantable pump assembly receives the drive signal from the processing unit and propels fluid based on the drive signal. The system includes a local communication device and a remote communication device that each include a unique identifier produced by a security key generator. The remote communication device includes a code generator that produces encrypted commands. The local communication device receives the encrypted commands and modifies a pump operational parameter of the processing unit based on the received encrypted command. | 2015-02-05 |
| 20150038772 | CONTROL OF BLOOD FLOW ASSIST SYSTEMS - A system for assisting blood flow in a patient includes an implantable pump system for assisting in blood flow from the heart and an implantable control system for communicative connection with the implantable pump system. The control system includes a pacemaker system that is operative to control heart rate and the pump system interdependently to achieve a determined level of blood flow assist. The control system is adapted to increase the heart rate of the patient to above a normal heart rate for the patient under the present conditions of the patient via the pacemaker while controlling the pump system to achieve the determined level of blood flow assist based upon the increased heart rate and a level of assist provided by the pump system. | 2015-02-05 |
| 20150038773 | THERMOTHERAPY DEVICE - A heat therapy appliance ( | 2015-02-05 |
| 20150038774 | BONE-SEALED AUDIO DEVICE - An audio device with an insertion part being adapted to be inserted into an ear canal of a user. The insertion part comprises pressure means and a resilient surface. The resilient surface comprises an adhesive, which is adapted to adhere to a skin portion of a bony portion of an ear canal of a user. The pressure means are adapted to provide a force to press the adhesive against the skin portion. The pressure means include a phase-changing material, which is adapted to cause a reduction in the force, when heat is supplied to the phase-changing material. | 2015-02-05 |
| 20150038775 | Systems, Devices, Components and Methods for Improved Acoustic Coupling Between a Bone Conduction Hearing Device and a Patient's Head or Skull - Disclosed are various embodiments of systems, devices, components and methods for improving acoustic coupling between a bone conduction hearing device (BCHD) and a patient's head or skull. Such systems, devices, components and methods include disposing a gel or paste between the BCHD and the patient's skin, hair and/or skull. The gel or paste improves the transmission of acoustic signals generated by a transducer in the BCHD to the patients head or skull by providing a more efficient and improved intermediary acoustic medium for the transmission of acoustic signals to the patient's head or skull. | 2015-02-05 |
| 20150038776 | DEVICE FOR INDUCING AND MAINTAINING SLEEP - Described herein is a device ( | 2015-02-05 |
| 20150038777 | TRANSOBTURATOR SURGICAL ARTICLES AND METHODS - A surgical instrument for treating incontinence includes a handle portion elongate along a handle axis and a needle portion connected to the handle portion. The needle portion has a spacer portion along the handle axis, and has a distal end. The needle portion includes a substantially helical portion that is a variable spiral portion, extending from the straight spacer portion. The variable spiral portion is sized and shaped to extend from an incision substantially adjacent the patient's obturator foramen through the obturator foramen along a path in a region between the superior pubic ramus and the inferior pubic ramus. The needle portion has a structure near the distal end that associates the instrument with an implantable material configured to treat incontinence. | 2015-02-05 |
| 20150038778 | ITIH5 AS A DIAGNOSTIC MARKER OF UTERINE DEVELOPMENT AND FUNCTIONAL DEFECTS - The invention relates to the use of ITIH5 as a biomarker of endometrium receptivity to embryo implantation. Also provided are methods and kits for using this biomarker for detecting the receptivity state of the endometrium of a mammal to embryo implantation, for diagnosing infertility in a female mammal, for the early diagnosis of pregnancy, for detecting the window of embryo implantation in the endometrium of a female mammal, for in vitrofertilization of a female mammal, and for diagnosing endometriosis. | 2015-02-05 |
| 20150038780 | HYSTEROPEXY MESH APPARATUSES AND METHODS - The invention describes embodiments of apparatuses and methods of using a hysteropexy mesh. | 2015-02-05 |
| 20150038781 | IMPLANT FOR HERNIA REPAIR - A hernia repair implant includes a first layer for facing a body structure having a hernia defect to cover the defect while promoting tissue growth into the first layer from the body structure. The implant also includes a second layer opposed to the first layer and made of anti-adhesion material to prevent growth of tissue into the second layer from body structures contacting the second layer. Furthermore, the implant includes at least one engagement strap connected to the first layer and extending therefrom to terminate at a free end. The engagement strap defines opposed the edges and opposed flat surfaces extending between the edges. At least one barb extends from at least one edge and/or at least one flat surface of the strap and is configured to impede motion of the strap in only a single direction. | 2015-02-05 |
| 20150038782 | IMPLANT FOR HERNIA REPAIR - A hernia repair implant includes a first layer for facing a body structure having a hernia defect to cover the defect while promoting tissue growth into the first layer from the body structure. The implant also includes a second layer opposed to the first layer and made of anti-adhesion material to prevent growth of tissue into the second layer from body structures contacting the second layer. Furthermore, the implant includes at least one engagement strap connected to the first layer and extending therefrom to terminate at a free end. The engagement strap defines opposed thin edges and opposed flat surfaces extending between the edges. At least one barb extends from at least one edge and/or at least one flat surface of the strap and is configured to impede motion of the strap in only a single direction. | 2015-02-05 |
| 20150038783 | IMPLANT FOR HERNIA REPAIR - A hernia repair implant includes a first layer for facing a body structure having a hernia defect so cover the defect while promoting tissue growth into the first layer from the body structure. The implant also includes a second layer opposed to the first layer and made of anti-adhesion material to prevent growth of tissue into the second layer from body structures contacting the second layer. Furthermore, the implant includes at least one engagement strap connected to the first layer and extending therefrom to terminate at a free end. The engagement strap defines opposed thin edges and opposed flat surfaces extending between the edges. At least one barb extends from at least one edge and/or at least one flat surface of the strap and is configured to impede motion of the strap in only a single direction. | 2015-02-05 |
| 20150038784 | ENDOSCOPE WORKING CHANNEL WITH MULTIPLE FUNCTIONALITY - Endoscopic instrument assemblies and methods for making and using the same. An example endoscopic instrument assembly includes an endoscope having a working channel and an endoscopic instrument slidably disposed in the working channel. The inside surface of the working channel and the outside surface of the endoscopic instrument each have a non-circular cross-sectional shape along at least a portion of their respective lengths. | 2015-02-05 |
| 20150038785 | INTEGRATED ENDOSCOPE IRRIGATION - In a first aspect the invention is an endoscopic device in which the empty spaces between the plurality of tubes, wires, and cables are utilized as a channel that enables liquid or gas to flow from the handle section to the distal tip. In a second aspect the invention is a method of reducing the diameter of an endoscope device by utilizing the empty spaces between the plurality of tubes, wires, and cables as a channel that enables liquid or gas to flow from the handle section to the distal tip. In a third aspect the invention is a distal tip comprising a pattern of alternating grooves and lands on its outer surface and a cap that fits tightly over the lands. The tight fitting cap changes the grooves into closed channels through which liquid or gas can flow. | 2015-02-05 |
| 20150038786 | SCANNING ENDOSCOPE SYSTEM - A scanning endoscope system includes: a fiber that guides illuminating light emitted from a light source; a first actuator provided on a side of the fiber, the first actuator expanding/contracting according to an applied voltage, thereby swinging the fiber; a second actuator disposed at a position facing the first actuator across the fiber, the second actuator expanding/contracting according to an applied voltage, thereby swinging the fiber; and a drive signal output section that applies a first drive signal that varies with reference to a first voltage that brings the first actuator into a contracted state to the first actuator and applies a second drive signal that varies with reference to a second voltage that brings the second actuator into a contracted state to the second actuator. | 2015-02-05 |
| 20150038787 | ENDOSCOPE - An endoscope includes illumination units and an image pickup unit that acquires an object image, in a distal end portion of an insertion portion. Each the illumination unit includes: a light-emitting section including an LED, the light-emitting section outputting light from an upper surface; a wiring board including a recess portion with the light-emitting section disposed therein, and a connection electrode connected to a device electrode of the LED via a relay electrode and an internal wiring in a first principal surface; a prism disposed above the upper surface of the light-emitting section with a transparent resin layer interposed therebetween, the prism changing a direction of the light outputted by the light-emitting section; and a signal cable connected to the connection electrode. | 2015-02-05 |
| 20150038788 | INSTRUMENT HAVING RADIO FREQUENCY IDENTIFICATION SYSTEMS AND METHODS FOR USE - One RFID equipped instrument includes an elongate body with a plurality of uniquely identified radio frequency identification chips spaced along the length of the elongate body. One system used for determining the position of an instrument includes an instrument; a plurality of radio frequency identification chips attached to the instrument; a reader connected to an antenna and adapted to communicate with each radio frequency identification chip using the antenna. | 2015-02-05 |
| 20150038789 | INJECTION TUBE FOR JET INJECTION DEVICE - A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or braiding. The non-metal, polymeric tubular device can be fabricated so as to have a burst strength exceeding at least about 2,000 psi. The non-metal, polymeric tubular device can be fabricated so as to have distention properties, wherein an orifice or jet port located at a distal end of the polymeric tubular device retains its shape and/or size without suffering swelling that can have a detrimental impact on a fluid jet used to deliver the therapeutic fluid at the treatment site. | 2015-02-05 |
| 20150038790 | METHOD AND APPARATUS FOR COLD PLASMA TREATMENT OF INTERNAL ORGANS - Chronic sinusitis is treated by the application of cold plasma or plasma-activated species to the infected mucosal surfaces through use of an endoscope having a steerable end which may be projected into the sinus cavities through the nasal cavity. The cold plasma is generated at either the distal end of the endoscope with a power source by application of a power, or at the distal end by gas and electrical connections extending through the endoscope. The cold plasma or plasma-activated species act to destroy bacterial cells but not eukaryotic cells. | 2015-02-05 |
| 20150038791 | Device For Use In A Surgical Procedure On An Human Eye - Presented is a device for use in a surgical procedure on an eye. The device includes an elongated member that includes a first elongated portion, a second elongated portion, and hook portion. The first elongated portion includes a proximal end and a distal end. The second elongated portion includes a proximal end and a distal end. The proximal end of the second elongated portion is coupled to the distal end of the first elongated portion. The second elongated portion extends from the first elongated portion at an angle to the longitudinal axis of the first elongated portion. The hook portion includes a proximal end and a distal end. The proximal end of the hook portion is coupled to the distal end of the second elongated member. | 2015-02-05 |
| 20150038792 | Instrument System For Minimally Invasive Surgery In Single Port Technology - An instrument system for minimally invasive surgery in single port technology, having a trocar and at least one instrument channel which runs at the trocar from proximal to distal and a proximal end remaining extra-corporally when the trocar is inserted into the body of a patient, and a distal end located intra-corporally, wherein a semi-flexible instrument can be inserted through the instrument channel in such a manner that the operating handle thereof remains extra-corporal and the distal working element thereof emerges distally from the instrument channel. The instrument channel is flexibly pliant, stable in the longitudinal direction thereof and arranged outside on the trocar. The distal end of the instrument channel is fixed to the trocar. | 2015-02-05 |
| 20150038793 | DEVICES, SYSTEMS, AND METHODS FOR PROVIDING SURGICAL ACCESS AND FACILITATING CLOSURE OF SURGICAL ACCESS OPENINGS - A surgical system includes a cannula and a guide member. The cannula is configured for positioning within an opening in tissue. The cannula includes a base and an elongated tubular member extending distally from the base. The elongated tubular member includes an annular wall defining a longitudinal passageway and defines at least one slot extending through the annular wall. The guide member includes a guide housing configured for releasably engaging the guide member with the cannula and an elongated guide shaft configured for insertion into the elongated tubular member of the cannula. The guide member defines at least one lumen extending therethrough and is configured such that, upon engagement of the guide member with the cannula, the at least one lumen is aligned with the at least one slot of the cannula to define a guide passageway through the guide member and cannula. | 2015-02-05 |
